» Articles » PMID: 8390614

Human Herpesvirus 6 in Lung Tissue from Patients with Pneumonitis After Bone Marrow Transplantation

Overview
Journal N Engl J Med
Specialty General Medicine
Date 1993 Jul 15
PMID 8390614
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Human herpesvirus 6 (HHV-6) is a recently described herpesvirus that is epidemiologically and biologically similar to cytomegalovirus. It is the cause of exanthem subitum (roseola) in children.

Methods: To evaluate the possible role of HHV-6 infection in pneumonitis in immunocompromised patients, we used quantitative HHV-6 polymerase chain reactions to study lung-biopsy specimens from 15 patients with pneumonitis after bone marrow transplantation and lung tissue from 15 immunocompetent subjects without pneumonitis and 6 fetuses.

Results: HHV-6 DNA was detected in lung tissue from all 15 patients, from 14 seropositive control subjects, and from none of the 7 seronegative control subjects. Six patients had levels of HHV-6 DNA in lung tissue that were 10 to 500 times higher than those in any of the other patients or control subjects. Increased levels of HHV-6 DNA correlated with a decreased risk of death from pneumonitis (P = 0.015), an increased severity of graft-versus-host disease (P = 0.023), and the presence of idiopathic pneumonitis (P = 0.037). Levels of HHV-6 DNA correlated directly with the changes in HHV-6 antibody titers in the interval between the pretransplantation period and the open-lung biopsy (P = 0.002). Low levels of HHV-6 antibody at the time of the open-lung biopsy were also associated with the diagnosis of idiopathic pneumonitis (P = 0.002).

Conclusions: The concentrations of HHV-6 genome in lung tissue and their relation to changes in serologic titers support an association between HHV-6 infection and idiopathic pneumonitis in immunocompromised hosts.

Citing Articles

A systematic review and meta-analysis of HHV-6 and mortality after hematopoietic cell transplant.

Stathis C, Zhu H, Carlin K, Phan T, Toomey D, Hill J Bone Marrow Transplant. 2024; 59(12):1683-1693.

PMID: 39245683 PMC: 11611739. DOI: 10.1038/s41409-024-02398-w.


HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant.

Hill J, Lee Y, Vande Vusse L, Xie H, Chung E, Waghmare A Nat Commun. 2024; 15(1):542.

PMID: 38228644 PMC: 10791683. DOI: 10.1038/s41467-024-44828-9.


Human herpes simplex virus-6 (HHV-6) detection and seroprevalence among Qatari nationals and immigrants residing in Qatar.

Al-Sadeq D, Zedan H, Aldewik N, Elkhider A, Hicazi A, Younes N IJID Reg. 2022; 2:90-95.

PMID: 35757074 PMC: 9216376. DOI: 10.1016/j.ijregi.2021.12.005.


Post-Transplantation Cyclophosphamide Is Associated with an Increase in Non-Cytomegalovirus Herpesvirus Infections in Patients with Acute Leukemia and Myelodysplastic Syndrome.

Singh A, Dandoy C, Chen M, Kim S, Mulroney C, Kharfan-Dabaja M Transplant Cell Ther. 2021; 28(1):48.e1-48.e10.

PMID: 34587551 PMC: 9717499. DOI: 10.1016/j.jtct.2021.09.015.


Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation.

Ward K, Hill J, Hubacek P, de la Camara R, Crocchiolo R, Einsele H Haematologica. 2019; 104(11):2155-2163.

PMID: 31467131 PMC: 6821622. DOI: 10.3324/haematol.2019.223073.